Gila Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A1

  • Investors
  • 9

Gila Therapeutics General Information

Description

Operator of a clinical-stage pharmaceutical company intended to treat obesity and prevent weight gain. The company develops and commercializes therapies for metabolic diseases, utilizing novel routes of administration, enabling individuals to lose weight and decrease calorie intake in a non-invasive and non-absorbed manner.

Contact Information

Website
www.gilatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Financial Center
  • Boston, MA 02111
  • United States
+1 (612)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • One Financial Center
  • Boston, MA 02111
  • United States
+1 (612)

Gila Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gila Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A1) 24-Apr-2025 Completed Clinical Trials - General
8. Later Stage VC 06-Dec-2023 Completed Clinical Trials - General
7. Later Stage VC 29-Nov-2022 Completed Clinical Trials - General
6. Later Stage VC 01-Mar-2022 Completed Clinical Trials - General
5. Later Stage VC 12-Nov-2021 Completed Clinical Trials - General
4. Later Stage VC (Series A) 11-Mar-2019 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Early Stage VC (Series A) 02-Mar-2017 $4M $4M Completed Startup
1. University Spin-Out 01-Jan-2014 Completed Startup
To view Gila Therapeutics’s complete valuation and funding history, request access »

Gila Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Gila Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Gila Therapeutics Patents

  • 44

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 24

    Pending

  • Expiring in next 12 mo

Gila Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025245916-A1 Compositions and methods for treating metabolic diseases with topical-lingual receptor agonists Pending 28-Mar-2024
WO-2025208093-A1 Compositions and methods for treating metabolic diseases with topical-lingual receptor agonists Pending 28-Mar-2024
EP-4366755-A1 Compositions and methods for activating a neural receptor Pending 08-Jul-2021
EP-4366755-A4 Compositions and methods for activating a neural receptor Pending 08-Jul-2021
US-20240342247-A1 Compositions and methods for activating a neural receptor Pending 08-Jul-2021 A61K38/22
To view Gila Therapeutics’s complete patent history, request access »

Gila Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gila Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
John Lilly Strategic Insights Corporation Minority
Lateral Capital Management Venture Capital Minority
Argonautic Ventures Venture Capital Minority
Broadview Ventures Venture Capital Minority
Harvard Business School Alumni Angels of Chicago Angel Group Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Gila Therapeutics FAQs

  • When was Gila Therapeutics founded?

    Gila Therapeutics was founded in 2014.

  • Where is Gila Therapeutics headquartered?

    Gila Therapeutics is headquartered in Boston, MA.

  • What is the size of Gila Therapeutics?

    Gila Therapeutics has 3 total employees.

  • What industry is Gila Therapeutics in?

    Gila Therapeutics’s primary industry is Drug Discovery.

  • Is Gila Therapeutics a private or public company?

    Gila Therapeutics is a Private company.

  • What is Gila Therapeutics’s current revenue?

    The current revenue for Gila Therapeutics is .

  • How much funding has Gila Therapeutics raised over time?

    Gila Therapeutics has raised $6.6M.

  • Who are Gila Therapeutics’s investors?

    John Lilly Strategic Insights, Lateral Capital Management, Argonautic Ventures, Broadview Ventures, and Harvard Business School Alumni Angels of Chicago are 5 of 9 investors who have invested in Gila Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process